Abstract
Antimicrobial diazanaphthalenes are indispensable in the treatment of various infections. The quinoxaline scaffold possesses unique physicochemical properties and provides a possibility of a great number of targeted modifications. Quinoxaline-based compounds have a wide range of promising biological properties; therefore a special attention is paid to them for research and designing of new drugs. In fact, quinoxaline can be considered as a privileged structure. The scaffold can be easily and rapidly constructed, which emphasizes the significance of this favourable structure. The review is focused on recently reported potential antibacterial, antimycobacterial, antifungal and antiprotozoal agents derived from the quinoxaline scaffold, their mechanism of action and structure-activity relationships. A brief classification of synthetic pathways of quinoxaline derivatives is provided too.
Keywords: Antibacterials, antifungals, antimycobacterial agents, antiprotozoals, quinoxalines, synthesis.
Current Medicinal Chemistry
Title:Recent Advances in Design of Potential Quinoxaline Anti-Infectives
Volume: 21 Issue: 38
Author(s): Josef Jampilek
Affiliation:
Keywords: Antibacterials, antifungals, antimycobacterial agents, antiprotozoals, quinoxalines, synthesis.
Abstract: Antimicrobial diazanaphthalenes are indispensable in the treatment of various infections. The quinoxaline scaffold possesses unique physicochemical properties and provides a possibility of a great number of targeted modifications. Quinoxaline-based compounds have a wide range of promising biological properties; therefore a special attention is paid to them for research and designing of new drugs. In fact, quinoxaline can be considered as a privileged structure. The scaffold can be easily and rapidly constructed, which emphasizes the significance of this favourable structure. The review is focused on recently reported potential antibacterial, antimycobacterial, antifungal and antiprotozoal agents derived from the quinoxaline scaffold, their mechanism of action and structure-activity relationships. A brief classification of synthetic pathways of quinoxaline derivatives is provided too.
Export Options
About this article
Cite this article as:
Jampilek Josef, Recent Advances in Design of Potential Quinoxaline Anti-Infectives, Current Medicinal Chemistry 2014; 21 (38) . https://dx.doi.org/10.2174/0929867321666141011194825
DOI https://dx.doi.org/10.2174/0929867321666141011194825 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Applications of Choline PET/CT in Brain Tumors
Current Pharmaceutical Design MDM4 (MDMX) and its Transcript Variants
Current Genomics ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design Autoimmunity and Frontotemporal Dementia
Current Alzheimer Research Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
Current Cancer Drug Targets Circular RNAs and Glioma: Small Molecule with Big Actions
Current Molecular Medicine Regulation of the Urokinase Receptor (uPAR) by LDL Receptor-related Protein-1 (LRP1)
Current Pharmaceutical Design mTOR in Growth and Protection of Hypertrophying Myocardium
Cardiovascular & Hematological Agents in Medicinal Chemistry A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Current Drug Safety CSPG4 in Cancer: Multiple Roles
Current Molecular Medicine Undermining Tumor Angiogenesis by Gene Therapy: An Emerging Field
Current Gene Therapy Immunological Mechanism and Clinical Application of PAMP Adjuvants
Recent Patents on Anti-Cancer Drug Discovery Interactions Between Cholinergic and Fibroblast Growth Factor Receptors in Brain Trophism and Plasticity
Current Protein & Peptide Science Cancer Stem Cells in Prostate Cancer Chemoresistance
Current Cancer Drug Targets Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review
Current Molecular Medicine TGF-β2 Signaling in High-Grade Gliomas
Current Pharmaceutical Biotechnology ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
Current Pharmaceutical Design Nanoparticulate Formulations for Paclitaxel Delivery Across MDCK Cell Monolayer
Current Pharmaceutical Design